Show Summary Details
Page of

Cardiac investigation—nuclear and other imaging techniques 

Cardiac investigation—nuclear and other imaging techniques

Chapter:
Cardiac investigation—nuclear and other imaging techniques
Author(s):

Nikant Sabharwal

, Andrew Kelion

, Theo Karamitsos

, and Stefan Neubauer

DOI:
10.1093/med/9780199204854.003.160303_update_002

Update:

Use of rogadenoson as a vasodilator in myocardial perfusion scanning (MPS). Prognostic value of MPS in patients with reversible ischaemia and its use in decision making in resvascularisation. The use of T1 and T2 imaging in detection of oedema in ischaemia, myocarditis and cardiomyopathies. Guidelines for use of CT calcium scoring and angiography in risk assessment and the assessment of chest pain.

Updated on 29 Oct 2015. The previous version of this content can be found here.
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2015. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy).

date: 25 July 2017

Myocardial perfusion scintigraphy (MPS) provides physiological information about the coronary circulation, in contrast to the anatomical information provided by angiography.

Three radionuclide-labelled perfusion tracers are routinely used in single photon emission computed tomography (SPECT) imaging: thallium-201 and the technetium-99 m-labelled complexes sestamibi and tetrofosmin. Imaging is performed following tracer injection during stress (exercise or pharmacological) and at rest; comparison allowing determination of whether regional perfusion is normal, or if there is inducible hypoperfusion or infarction/scar....

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.